Pro Test Diagnostics AB


Umeå-based diagnostics company developing a laboratory test kit to detect autologous blood transfusion (autologous blood doping). The company applies proteomics-based methods (liquid chromatography coupled to mass spectrometry), sample-preparation workflows, multivariate statistics and planned AI tools to identify biomarkers associated with long-term frozen storage of red blood cells. The organisation collaborates with accredited anti-doping laboratories and has progressed through pilot production, validation and funding rounds.

Industries

health-diagnostics
pharmaceutical

Nr. of Employees

small (1-50)

Pro Test Diagnostics AB

Umeå, Vasterbottens Lan, Sweden, Europe


Products

Diagnostic kit for detection of autologous blood transfusion

A laboratory test kit designed to detect molecular fingerprint changes in blood caused by long-term frozen storage and re-infusion of an individual's own blood.


Services

Assay validation and laboratory transfer

Validation testing and analytical transfer of the autologous blood transfusion detection assay to accredited anti-doping laboratories for use in routine testing.

Proteomics data analysis and interpretation

Processing and statistical analysis of proteomics datasets to identify biomarkers indicative of stored/frozen red blood cells.

Expertise Areas

  • Proteomics-based biomarker discovery
  • LC-MS/MS analytical workflows for blood samples
  • Diagnostic assay development for anti-doping
  • Clinical study design and sample management
  • Show More (4)

Key Technologies

  • Liquid chromatography-mass spectrometry (LC-MS/MS)
  • Nano-scale reversed-phase chromatography (nano-UHPLC)
  • Electrospray ionization QTOF mass spectrometry
  • Label-free proteomics
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.